Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Common Equity: 2025

Historic Common Equity for Dr Reddys Laboratories (RDY) over the last 1 years, with Mar 2025 value amounting to $3.9 billion.

  • Dr Reddys Laboratories' Common Equity was N/A to $3.9 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $3.9 billion, marking a year-over-year change of. This contributed to the annual value of $3.9 billion for FY2025, which is N/A change from last year.
  • Latest data reveals that Dr Reddys Laboratories reported Common Equity of $3.9 billion as of FY2025.
  • Over the past 5 years, Dr Reddys Laboratories' Common Equity peaked at $3.9 billion during FY2025, and registered a low of $3.9 billion during FY2025.
  • Moreover, its 1-year median value for Common Equity was $3.9 billion (2025), whereas its average is $3.9 billion.